571 results on '"Yoo, Seung Soo"'
Search Results
2. Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B
3. Different characteristics of pleural abnormalities on computed tomography between tuberculous and malignant pleural effusions
4. Clinical relevance of bronchiectasis in patients with community-acquired pneumonia
5. CyTOF analysis for differential immune cellular profiling between latent tuberculosis infection and active tuberculosis
6. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer
7. Role of Chest Computed Tomography in Patients Hospitalized with Community-Acquired Complicated Parapneumonic Effusion or Empyema
8. Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia
9. Pectoralis Muscle Area as a Predictor of Mortality in Patients Hospitalized with Bronchiectasis Exacerbation
10. The role of CECR1 in the immune-modulatory effects of butyrate and correlation between ADA2 and M1/M2 chemokines in tuberculous pleural effusion
11. Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome
12. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
13. Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia
14. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions
15. Comparison of biochemical parameters and chemokine levels in pleural fluid between patients with anergic and non-anergic tuberculous pleural effusion
16. Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion
17. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy
18. Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome
19. Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma
20. Clinical and radiological features of pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis
21. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions
22. An expression quantitative trait locus variant for LKB1 gene predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer
23. Risk factors for mortality in patients with Stenotrophomonas maltophilia pneumonia in intensive care unit
24. Relationship Between Clinical Features and Computed Tomographic Findings in Hospitalized Adult Patients With Community-Acquired Pneumonia
25. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery
26. Lipid Metabolism Pathway Genes and Lung Cancer: ACADSB rs12220683G>C Is Associated with Better Survival Outcome in Patients with Non-Small Cell Lung Cancer
27. Genetic variants in key necroptosis regulators predict prognosis of non‐small cell lung cancer after surgical resection
28. Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea
29. Clinical predictors and outcomes of non-expandable lung following percutaneous catheter drainage in lung cancer patients with malignant pleural effusion
30. Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion
31. Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial
32. Clinical Characteristics of Coexisting Pulmonary Thromboembolism in Patients With Respiratory Tuberculosis
33. Lipid Metabolism Pathway Genes and Lung Cancer: ACADSB rs12220683G>C Is Associated with Better Survival Outcome in Patients with Non-Small Cell Lung Cancer.
34. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer
35. Incidental versus symptomatic pulmonary embolism in patients without cancer
36. Supplementary Figure 2 from A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer
37. Supplementary Figure 1 from A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer
38. Supplementary Table 1 from A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer
39. Supplementary Figure 3 from A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer
40. Supplementary Figure Legend from A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer
41. Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
42. Epigenetic and genetic inactivation of tumor suppressormiR‐135a in non‐small‐cell lung cancer
43. Risk factors for mortality in patients with septic pulmonary embolism
44. Neutrophilic Loculated Tuberculous Pleural Effusion: Incidence, Characteristics and Differentiation From Complicated Parapneumonic Effusion
45. An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients
46. Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
47. Putative functional variants of XRCC1 identified by RegulomeDB were not associated with lung cancer risk in a Korean population
48. sj-docx-2-vmj-10.1177_1358863X231171614 – Supplemental material for Incidental versus symptomatic pulmonary embolism in patients without cancer
49. Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer
50. Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.